The previous analyses of Nrf2 expression or activation in human tumors have revealed that high Nrf2 expression or activation correlated with poor prognosis in hepatocellular carcinoma and pancreatic cancer [44, 45]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.